Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Return on Equity (2016 - 2025)

Catalyst Pharmaceuticals (CPRX) has disclosed Return on Equity for 15 consecutive years, with 0.23% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity fell 1.0% year-over-year to 0.23%, compared with a TTM value of 0.23% through Dec 2025, down 1.0%, and an annual FY2025 reading of 0.25%, down 4.0% over the prior year.
  • Return on Equity was 0.23% for Q4 2025 at Catalyst Pharmaceuticals, down from 0.24% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.41% in Q1 2021 and bottomed at 0.09% in Q2 2024.
  • Average Return on Equity over 5 years is 0.25%, with a median of 0.24% recorded in 2024.
  • The sharpest move saw Return on Equity crashed -32bps in 2021, then rose 17bps in 2025.
  • Year by year, Return on Equity stood at 0.19% in 2021, then surged by 82bps to 0.35% in 2022, then plummeted by -59bps to 0.15% in 2023, then soared by 62bps to 0.24% in 2024, then fell by -3bps to 0.23% in 2025.
  • Business Quant data shows Return on Equity for CPRX at 0.23% in Q4 2025, 0.24% in Q3 2025, and 0.25% in Q2 2025.